{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:22:01Z","timestamp":1648923721632},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00292-017-0292-y","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T04:25:20Z","timestamp":1493871920000},"page":"186-196","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heredit\u00e4re Tumorsyndrome in der Neuropathologie"],"prefix":"10.1007","volume":"38","author":[{"given":"C.","family":"Mawrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,4]]},"reference":[{"issue":"4","key":"292_CR1","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr.","year":"1971","unstructured":"Knudson AG Jr. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820\u2013823","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"292_CR2","doi-asserted-by":"crossref","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","volume":"11","author":"ME Tyburczy","year":"2015","unstructured":"Tyburczy ME, Dies KA, Glass J et\u00a0al (2015) Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLOS Genet 11(11):e1005637","journal-title":"PLOS Genet."},{"issue":"4","key":"292_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.spen.2015.11.001","volume":"22","author":"M Ruggieri","year":"2015","unstructured":"Ruggieri M, Pratico AD (2015) Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 22(4):207\u2013233","journal-title":"Semin Pediatr Neurol"},{"issue":"2","key":"292_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152a","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a\u00a0UK family genetic register service. Am J Med Genet\u00a0A 152a(2):327\u2013332","journal-title":"Am J Med Genet A"},{"issue":"2","key":"292_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N et\u00a0al (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J\u00a0Med Genet 44(2):81\u201388","journal-title":"J. Med. Genet."},{"issue":"3","key":"292_CR6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1101\/gr.142604.112","volume":"23","author":"DH Gutmann","year":"2013","unstructured":"Gutmann DH, McLellan MD, Hussain I et al (2013) Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma. Genome Res 23(3):431\u2013439","journal-title":"Genome Res."},{"issue":"21","key":"292_CR7","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","volume":"88","author":"DH Gutmann","year":"1991","unstructured":"Gutmann DH, Wood DL, Collins FS (1991) Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 88(21):9658\u20139662","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"292_CR8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.055772","volume":"45","author":"E Denayer","year":"2008","unstructured":"Denayer E, de Ravel T, Legius E (2008) Clinical and molecular aspects of RAS related disorders. J\u00a0Med Genet 45(11):695\u2013703","journal-title":"J. Med. Genet."},{"issue":"8","key":"292_CR9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a\u00a0multidisciplinary approach to care. Lancet Neurol 13(8):834\u2013843","journal-title":"Lancet Neurol"},{"issue":"5","key":"292_CR10","first-page":"1573","volume":"62","author":"RE Ferner","year":"2002","unstructured":"Ferner RE, Gutmann DH (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62(5):1573\u20131577","journal-title":"Cancer Res."},{"issue":"9","key":"292_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1346-8138.2006.00148.x","volume":"33","author":"E Sezer","year":"2006","unstructured":"Sezer E, Senayli A, Sezer T, Bicakci U (2006) Segmental neurofibromatosis: report of two cases. J\u00a0Dermatol 33(9):635\u2013638","journal-title":"J. Dermatol."},{"issue":"6","key":"292_CR12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","volume":"79","author":"HW Dodge Jr.","year":"1958","unstructured":"Dodge HW Jr., Love JG, Craig WM et\u00a0al (1958) Gliomas of the optic nerves. Ama Arch Neurol Psychiatry 79(6):607\u2013621","journal-title":"Ama Arch Neurol Psychiatry"},{"issue":"3","key":"292_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R, Ferner RE, Liu GT, Gutmann DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61(3):189\u2013198","journal-title":"Ann Neurol"},{"issue":"2","key":"292_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1006244724476","volume":"42","author":"T Czech","year":"1999","unstructured":"Czech T, Slavc I, Aichholzer M et al (1999) Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children. J\u00a0Neurooncol 42(2):143\u2013150","journal-title":"J Neurooncol"},{"issue":"8","key":"292_CR15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1212\/01.wnl.0000240076.31298.47","volume":"67","author":"JR Leonard","year":"2006","unstructured":"Leonard JR, Perry A, Rubin JB, King AA, Chicoine MR, Gutmann DH (2006) The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology 67(8):1509\u20131512","journal-title":"Neurology"},{"issue":"3","key":"292_CR16","first-page":"E81","volume":"6","author":"C Lu-Emerson","year":"2009","unstructured":"Lu-Emerson C, Plotkin SR (2009) The neurofibromatoses. Part 2: NF2 and schwannomatosis. Rev Neurol Dis 6(3):E81\u2013E86","journal-title":"Rev Neurol Dis"},{"issue":"1","key":"292_CR17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a\u00a010-year period: higher incidence than previously thought. Otol Neurotol 26(1):93\u201397","journal-title":"Otol Neurotol"},{"issue":"3","key":"292_CR18","first-page":"156","volume":"8","author":"JD Dang","year":"2010","unstructured":"Dang JD, Cohen PR (2010) Segmental neurofibromatosis and malignancy. Skinmed 8(3):156\u2013159","journal-title":"Skinmed"},{"issue":"5","key":"292_CR19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","volume":"72","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL et al (1993) A novel moesin-, ezrin-, radixin-like gene is a\u00a0candidate for the neurofibromatosis 2 tumor suppressor. Cell 72(5):791\u2013800","journal-title":"Cell"},{"issue":"3","key":"292_CR20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7","volume":"51","author":"HM Xu","year":"1998","unstructured":"Xu HM, Gutmann DH (1998) Merlin differentially associates with the microtubule and actin cytoskeleton. J\u00a0Neurosci Res 51(3):403\u2013415","journal-title":"J Neurosci Res"},{"issue":"5","key":"292_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2015.125","volume":"35","author":"AM Petrilli","year":"2016","unstructured":"Petrilli AM, Fernandez-Valle C (2016) Role of Merlin\/NF2 inactivation in tumor biology. Oncogene 35(5):537\u2013548","journal-title":"Oncogene"},{"issue":"2","key":"292_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1750-3639.1995.tb00590.x","volume":"5","author":"DN Louis","year":"1995","unstructured":"Louis DN, Ramesh V, Gusella JF (1995) Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5(2):163\u2013172","journal-title":"Brain Pathol"},{"issue":"4","key":"292_CR23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3171\/jns.1997.87.4.0610","volume":"87","author":"J Antinheimo","year":"1997","unstructured":"Antinheimo J, Haapasalo H, Haltia M et al (1997) Proliferation potential and histological features in neurofibromatosis 2\u2011associated and sporadic meningiomas. J Neurosurg 87(4):610\u2013614","journal-title":"J. Neurosurg."},{"issue":"1","key":"292_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02688690500081206","volume":"19","author":"DG Evans","year":"2005","unstructured":"Evans DG, Baser ME, O\u2019Reilly B et\u00a0al (2005) Management of the patient and family with neurofibromatosis 2: a\u00a0consensus conference statement. Br J Neurosurg 19(1):5\u201312","journal-title":"Br J Neurosurg"},{"issue":"1","key":"292_CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jmg.2004.023705","volume":"42","author":"DG Evans","year":"2005","unstructured":"Evans DG, Watson C, King A, Wallace AJ, Baser ME (2005) Multiple meningiomas: differential involvement of the NF2 gene in children and adults. J\u00a0Med Genet 42(1):45\u201348","journal-title":"J. Med. Genet."},{"issue":"4","key":"292_CR26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","volume":"71","author":"ME Baser","year":"2002","unstructured":"Baser ME, Friedman JM, Aeschliman D et\u00a0al (2002) Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71(4):715\u2013723","journal-title":"Am J Hum Genet"},{"issue":"1","key":"292_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00006123-199601000-00009","volume":"38","author":"M Lee","year":"1996","unstructured":"Lee M, Rezai AR, Freed D, Epstein FJ (1996) Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery 38(1):32\u201337","journal-title":"Neurosurgery"},{"issue":"10","key":"292_CR28","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00115-002-1356-6","volume":"73","author":"S Meyer","year":"2002","unstructured":"Meyer S, Romeike B, Strowitzki M et al (2002) Meningioangiomatosis with associated meningioma in a\u00a04-year-old girl presenting with a\u00a0focal seizure. Nervenarzt 73(10):990\u2013994","journal-title":"Nervenarzt"},{"key":"292_CR29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.1986.tb48058.x","volume":"486","author":"LJ Rubinstein","year":"1986","unstructured":"Rubinstein LJ (1986) The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropathological study of 22 cases. Ann N Y Acad Sci 486:14\u201329","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"292_CR30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nn.3348","volume":"16","author":"A Schulz","year":"2013","unstructured":"Schulz A, Baader SL, Niwa-Kawakita M et al (2013) Merlin isoform 2 in neurofibromatosis type 2\u2011associated polyneuropathy. Nat Neurosci 16(4):426\u2013433","journal-title":"Nat. Neurosci."},{"issue":"11","key":"292_CR31","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1212\/01.WNL.0000163982.78900.AD","volume":"64","author":"M MacCollin","year":"2005","unstructured":"MacCollin M, Chiocca EA, Evans DG et\u00a0al (2005) Diagnostic criteria for schwannomatosis. Neurology 64(11):1838\u20131845","journal-title":"Neurology"},{"issue":"1","key":"292_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10048-009-0204-2","volume":"11","author":"C Bacci","year":"2010","unstructured":"Bacci C, Sestini R, Provenzano A et\u00a0al (2010) Schwannomatosis associated with multiple meningiomas due to a\u00a0familial SMARCB1 mutation. Neurogenetics 11(1):73\u201380","journal-title":"Neurogenetics"},{"issue":"2","key":"292_CR33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jmg.2010.082420","volume":"48","author":"I Christiaans","year":"2011","unstructured":"Christiaans I, Kenter SB, Brink HC et\u00a0al (2011) Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J\u00a0Med Genet 48(2):93\u201397","journal-title":"J. Med. Genet."},{"issue":"1","key":"292_CR34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jmg.2008.060152","volume":"46","author":"JJ Swensen","year":"2009","unstructured":"Swensen JJ, Keyser J, Coffin CM, Biegel JA, Viskochil DH, Williams MS (2009) Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a\u00a0duplication in SMARCB1. J\u00a0Med Genet 46(1):68\u201372","journal-title":"J. Med. Genet."},{"issue":"10","key":"292_CR35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1634\/theoncologist.2012-0162","volume":"17","author":"VL Merker","year":"2012","unstructured":"Merker VL, Esparza S, Smith MJ, Stemmer-Rachamimov A, Plotkin SR (2012) Clinical features of schwannomatosis: a\u00a0retrospective analysis of 87 patients. Oncologist 17(10):1317\u20131322","journal-title":"Oncologist"},{"issue":"4","key":"292_CR36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.46.4.1072","volume":"46","author":"M MacCollin","year":"1996","unstructured":"MacCollin M, Woodfin W, Kronn D, Short MP (1996) Schwannomatosis: a\u00a0clinical and pathologic study. Neurology 46(4):1072\u20131079","journal-title":"Neurology"},{"issue":"5","key":"292_CR37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/01.wnl.0000201190.89751.41","volume":"66","author":"ME Baser","year":"2006","unstructured":"Baser ME, Friedman JM, Evans DG (2006) Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology 66(5):730\u2013732","journal-title":"Neurology"},{"issue":"1","key":"292_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.54.1.71","volume":"54","author":"J Antinheimo","year":"2000","unstructured":"Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54(1):71\u201376","journal-title":"Neurology"},{"issue":"6","key":"292_CR39","doi-asserted-by":"crossref","first-page":"W646","DOI":"10.2214\/AJR.12.8577","volume":"200","author":"NA Koontz","year":"2013","unstructured":"Koontz NA, Wiens AL, Agarwal A, Hingtgen CM, Emerson RE, Mosier KM (2013) Schwannomatosis: the overlooked neurofibromatosis? AJR Am J Roentgenol 200(6):W646\u2013W653","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"292_CR40","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/513207","volume":"80","author":"TJ Hulsebos","year":"2007","unstructured":"Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P (2007) Germline mutation of INI1\/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80(4):805\u2013810","journal-title":"Am J Hum Genet"},{"issue":"6","key":"292_CR41","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/jmg.2007.056499","volume":"45","author":"KD Hadfield","year":"2008","unstructured":"Hadfield KD, Newman WG, Bowers NL et\u00a0al (2008) Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J\u00a0Med Genet 45(6):332\u2013339","journal-title":"J. Med. Genet."},{"issue":"2","key":"292_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10048-012-0319-8","volume":"13","author":"MJ Smith","year":"2012","unstructured":"Smith MJ, Wallace AJ, Bowers NL et\u00a0al (2012) Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics 13(2):141\u2013145","journal-title":"Neurogenetics"},{"issue":"2","key":"292_CR43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ng.2855","volume":"46","author":"A Piotrowski","year":"2014","unstructured":"Piotrowski A, Xie J, Liu YF et al (2014) Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 46(2):182\u2013187","journal-title":"Nat Genet"},{"issue":"1","key":"292_CR44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pbc.22831","volume":"56","author":"KW Eaton","year":"2011","unstructured":"Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA (2011) Spectrum of SMARCB1\/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56(1):7\u201315","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"292_CR45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cancergen.2014.04.001","volume":"207","author":"MJ Smith","year":"2014","unstructured":"Smith MJ, Wallace AJ, Bowers NL, Eaton H, Evans DG (2014) SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genet 207(9):373\u2013378","journal-title":"Cancer Genet"},{"issue":"2","key":"292_CR46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00439-016-1753-8","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Farschtschi S, Mautner VF, Cooper DN (2017) The molecular pathogenesis of schwannomatosis, a\u00a0paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis. Hum Genet 136(2):129\u2013148","journal-title":"Hum. Genet."},{"key":"292_CR47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 615:125\u2013127","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"292_CR48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000254570","volume":"33","author":"PJ Morrison","year":"2009","unstructured":"Morrison PJ (2009) Tuberous sclerosis: epidemiology, genetics and progress towards treatment. Neuroepidemiology 33(4):342\u2013343","journal-title":"Neuroepidemiology"},{"key":"292_CR49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","volume":"1184","author":"KA Orlova","year":"2010","unstructured":"Orlova KA, Crino PB (2010) The tuberous sclerosis complex. Ann N Y Acad Sci 1184:87\u2013105","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"292_CR50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","volume":"25","author":"CC Dibble","year":"2015","unstructured":"Dibble CC, Cantley LC (2015) Regulation of mTORC1 by PI3K signaling. Trends Cell Biol 25(9):545\u2013555","journal-title":"Trends Cell Biol."},{"issue":"2","key":"292_CR51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au KS, Williams AT, Roach ES et\u00a0al (2007) Genotype\/phenotype correlation in 325 individuals referred for a\u00a0diagnosis of tuberous sclerosis complex in the United States. Genet Med 9(2):88\u2013100","journal-title":"Genet. Med."},{"issue":"8943","key":"292_CR52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0140-6736(95)90213-9","volume":"345","author":"S Verhoef","year":"1995","unstructured":"Verhoef S, Vrtel R, van Essen T et\u00a0al (1995) Somatic mosaicism and clinical variation in tuberous sclerosis complex. Lancet 345(8943):202","journal-title":"Lancet"},{"issue":"6","key":"292_CR53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","volume":"49","author":"J Roth","year":"2013","unstructured":"Roth J, Roach ES, Bartels U et\u00a0al (2013) Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 49(6):439\u2013444","journal-title":"Pediatr Neurol"},{"issue":"6","key":"292_CR54","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","volume":"80","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Care MM, Agricola K, Tudor C, Mays M, Franz DN (2013) Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma. Neurology 80(6):574\u2013580","journal-title":"Neurology"},{"issue":"10","key":"292_CR55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/088307380001501003","volume":"15","author":"S Jozwiak","year":"2000","unstructured":"Jozwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J (2000) Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 15(10):652\u2013659","journal-title":"J. Child Neurol."},{"issue":"3","key":"292_CR56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.66.3.370","volume":"66","author":"R Nabbout","year":"1999","unstructured":"Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C (1999) Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J\u00a0Neurol Neurosurg Psychiatr 66(3):370\u2013375","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"7","key":"292_CR57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","volume":"28","author":"ER Maher","year":"1991","unstructured":"Maher ER, Iselius L, Yates JR et al (1991) Von Hippel-Lindau disease: a\u00a0genetic study. J Med Genet 28(7):443\u2013447","journal-title":"J. Med. Genet."},{"issue":"6161","key":"292_CR58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","volume":"332","author":"BR Seizinger","year":"1988","unstructured":"Seizinger BR, Rouleau GA, Ozelius LJ et al (1988) Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332(6161):268\u2013269","journal-title":"Nature"},{"issue":"2","key":"292_CR59","first-page":"231","volume":"75","author":"M Los","year":"1996","unstructured":"Los M, Jansen GH, Kaelin WG, Lips CJ, Blijham GH, Voest EE (1996) Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 75(2):231\u2013238","journal-title":"Lab Invest"},{"issue":"1","key":"292_CR60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER (2015) VHL, the story of a\u00a0tumour suppressor gene. Nat Rev Cancer 15(1):55\u201364","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"292_CR61","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","volume":"5","author":"F Chen","year":"1995","unstructured":"Chen F, Kishida T, Yao M et al (1995) Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5(1):66\u201375","journal-title":"Hum Mutat"},{"issue":"10","key":"292_CR62","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","volume":"10","author":"MA Hoffman","year":"2001","unstructured":"Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG Jr. (2001) von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 10(10):1019\u20131027","journal-title":"Hum Mol Genet"},{"issue":"14","key":"292_CR63","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/onc.2009.12","volume":"28","author":"CM Lee","year":"2009","unstructured":"Lee CM, Hickey MM, Sanford CA et\u00a0al (2009) VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo. Oncogene 28(14):1694\u20131705","journal-title":"Oncogene"},{"issue":"6","key":"292_CR64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1399-0004.2010.01464.x","volume":"79","author":"AD Sorrell","year":"2011","unstructured":"Sorrell AD, Lee S, Stolle C et\u00a0al (2011) Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma. Clin Genet 79(6):539\u2013545","journal-title":"Clin. Genet."},{"issue":"6","key":"292_CR65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2796.1998.00337.x","volume":"243","author":"S Richard","year":"1998","unstructured":"Richard S, Campello C, Taillandier L, Parker F, Resche F (1998) Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group. J Intern Med 243(6):547\u2013553","journal-title":"J. Intern. Med."},{"key":"292_CR66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-7091-6912-4_6","volume":"20","author":"F Resche","year":"1993","unstructured":"Resche F, Moisan JP, Mantoura J et al (1993) Haemangioblastoma, haemangioblastomatosis, and von Hippel-Lindau disease. Adv Tech Stand Neurosurg 20:197\u2013304","journal-title":"Adv Tech Stand Neurosurg"},{"key":"292_CR67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymeth.2014.10.011","volume":"77\u201378","author":"J Ngeow","year":"2015","unstructured":"Ngeow J, Eng C (2015) PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol. Methods 77\u201378:11\u201319","journal-title":"Methods"},{"issue":"3","key":"292_CR68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.ejhg.5200289","volume":"7","author":"MR Nelen","year":"1999","unstructured":"Nelen MR, Kremer H, Konings IB et al (1999) Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet 7(3):267\u2013273","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"292_CR69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0596-114","volume":"13","author":"MR Nelen","year":"1996","unstructured":"Nelen MR, Padberg GW, Peeters EA et al (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13(1):114\u2013116","journal-title":"Nat Genet"},{"issue":"3","key":"292_CR70","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/hmg\/7.3.507","volume":"7","author":"DJ Marsh","year":"1998","unstructured":"Marsh DJ, Coulon V, Lunetta KL et al (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7(3):507\u2013515","journal-title":"Hum Mol Genet"},{"issue":"12","key":"292_CR71","doi-asserted-by":"crossref","first-page":"E2063","DOI":"10.1210\/jc.2011-1616","volume":"96","author":"J Ngeow","year":"2011","unstructured":"Ngeow J, Mester J, Rybicki LA, Ni Y, Milas M, Eng C (2011) Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab 96(12):E2063\u2013E2071","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"292_CR72","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","volume":"18","author":"MH Tan","year":"2012","unstructured":"Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18(2):400\u2013407","journal-title":"Clin Cancer Res"},{"issue":"5","key":"292_CR73","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1086\/379382","volume":"73","author":"XP Zhou","year":"2003","unstructured":"Zhou XP, Marsh DJ, Morrison CD et al (2003) Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase\/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet 73(5):1191\u20131198","journal-title":"Am J Hum Genet"},{"issue":"1","key":"292_CR74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2990.2009.01041.x","volume":"36","author":"E Kirches","year":"2010","unstructured":"Kirches E, Steiner J, Schneider T et al (2010) Lhermitte-Duclos disease caused by a\u00a0novel germline PTEN mutation R173P in a\u00a0patient presenting with psychosis. Neuropathol Appl Neurobiol 36(1):86\u201389","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9363","key":"292_CR75","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","volume":"361","author":"F Lalloo","year":"2003","unstructured":"Lalloo F, Varley J, Ellis D et al (2003) Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361(9363):1101\u20131102","journal-title":"Lancet"},{"issue":"8","key":"292_CR76","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","volume":"27","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Noltner KA, Buzin CH et\u00a0al (2009) Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J\u00a0Clin Oncol 27(8):1250\u20131256","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"292_CR77","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmg.2008.058958","volume":"46","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Buzin CH, Noltner KA et al (2009) High frequency of de novo mutations in Li-Fraumeni syndrome. J Med Genet 46(10):689\u2013693","journal-title":"J. Med. Genet."},{"issue":"3","key":"292_CR78","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137(3):413\u2013431","journal-title":"Cell"},{"issue":"4985","key":"292_CR79","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC et\u00a0al (1990) Germ line p53 mutations in a\u00a0familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250(4985):1233\u20131238","journal-title":"Science"},{"issue":"23","key":"292_CR80","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","volume":"122","author":"PL Mai","year":"2016","unstructured":"Mai PL, Best AF, Peters JA et al (2016) Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer 122(23):3673\u20133681","journal-title":"Cancer"},{"issue":"1","key":"292_CR81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","volume":"17","author":"AD Sorrell","year":"2013","unstructured":"Sorrell AD, Espenschied CR, Culver JO, Weitzel JN (2013) Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions. Mol Diagn Ther 17(1):31\u201347","journal-title":"Mol Diagn Ther"},{"issue":"12","key":"292_CR82","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.2009.26.8169","volume":"28","author":"U Tabori","year":"2010","unstructured":"Tabori U, Shlien A, Baskin B et\u00a0al (2010) TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J\u00a0Clin Oncol 28(12):1995\u20132001","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"292_CR83","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ejca.2013.12.005","volume":"50","author":"D Bakry","year":"2014","unstructured":"Bakry D, Aronson M, Durno C et\u00a0al (2014) Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer 50(5):987\u2013996","journal-title":"Eur J Cancer"},{"key":"292_CR84","first-page":"95","volume":"8","author":"ML Leoz","year":"2015","unstructured":"Leoz ML, Carballal S, Moreira L, Ocana T, Balaguer F (2015) The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet 8:95\u2013107","journal-title":"Appl Clin Genet"},{"issue":"2","key":"292_CR85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","volume":"33","author":"EM Stoffel","year":"2015","unstructured":"Stoffel EM, Mangu PB, Gruber SB et al (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33(2):209\u2013217","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"292_CR86","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/ene.12647","volume":"22","author":"C Therkildsen","year":"2015","unstructured":"Therkildsen C, Ladelund S, Rambech E, Persson A, Petersen A, Nilbert M (2015) Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome. Eur J Neurol 22(4):717\u2013724","journal-title":"Eur J Neurol"},{"issue":"5","key":"292_CR87","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clineuro.2010.12.011","volume":"113","author":"ZA Binder","year":"2011","unstructured":"Binder ZA, Johnson MW, Joshi A et al (2011) Glioblastoma multiforme in the Muir-Torre syndrome. Clin Neurol Neurosurg 113(5):411\u2013415","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"292_CR88","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.11537","volume":"98","author":"SF Amlashi","year":"2003","unstructured":"Amlashi SF, Riffaud L, Brassier G, Morandi X (2003) Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 98(3):618\u2013624","journal-title":"Cancer"},{"issue":"5","key":"292_CR89","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/bjc.1991.435","volume":"64","author":"DG Evans","year":"1991","unstructured":"Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM (1991) The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64(5):959\u2013961","journal-title":"Br J Cancer"},{"issue":"5","key":"292_CR90","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jmg.2007.055343","volume":"45","author":"Z Fan","year":"2008","unstructured":"Fan Z, Li J, Du J et\u00a0al (2008) A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a\u00a0Chinese family. J\u00a0Med Genet 45(5):303\u2013308","journal-title":"J. Med. Genet."},{"issue":"17","key":"292_CR91","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1200\/JCO.2011.38.7258","volume":"30","author":"L Brugieres","year":"2012","unstructured":"Brugieres L, Remenieras A, Pierron G et\u00a0al (2012) High frequency of germline SUFU mutations in children with desmoplastic\/nodular medulloblastoma younger than 3 years of age. J\u00a0Clin Oncol 30(17):2087\u20132093","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"292_CR92","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1158\/1078-0432.CCR-08-2023","volume":"15","author":"ML Garre","year":"2009","unstructured":"Garre ML, Cama A, Bagnasco F et al (2009) Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome \u2013 a new clinical perspective. Clin Cancer Res 15(7):2463\u20132471","journal-title":"Clin Cancer Res"},{"issue":"1","key":"292_CR93","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/foc.2006.20.1.12","volume":"20","author":"JA Biegel","year":"2006","unstructured":"Biegel JA (2006) Molecular genetics of atypical teratoid\/rhabdoid tumor. Neurosurg Focus 20(1):E11","journal-title":"Neurosurg Focus"},{"issue":"4","key":"292_CR94","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-014-1318-7","volume":"128","author":"L Kock de","year":"2014","unstructured":"de Kock L, Sabbaghian N, Druker H et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128(4):583\u2013595","journal-title":"Acta Neuropathol"},{"issue":"1","key":"292_CR95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","volume":"128","author":"L Kock de","year":"2014","unstructured":"de Kock L, Sabbaghian N, Plourde F et al (2014) Pituitary blastoma: a\u00a0pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol 128(1):111\u2013122","journal-title":"Acta Neuropathol"},{"issue":"21","key":"292_CR96","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM198705213162101","volume":"316","author":"M Swift","year":"1987","unstructured":"Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N\u00a0Engl J Med 316(21):1289\u20131294","journal-title":"N Engl J Med"},{"issue":"5218","key":"292_CR97","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K, Bar-Shira A, Gilad S et al (1995) A single ataxia telangiectasia gene with a\u00a0product similar to PI-3 kinase. Science 268(5218):1749\u20131753","journal-title":"Science"},{"issue":"3","key":"292_CR98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-006-9275-1","volume":"82","author":"BS Malmer","year":"2007","unstructured":"Malmer BS, Feychting M, Lonn S et\u00a0al (2007) Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J\u00a0Neurooncol 82(3):229\u2013237","journal-title":"J Neurooncol"},{"issue":"1","key":"292_CR99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00381-013-2309-z","volume":"30","author":"AM Ranger","year":"2014","unstructured":"Ranger AM, Patel YK, Chaudhary N, Anantha RV (2014) Familial syndromes associated with intracranial tumours: a\u00a0review. Childs Nerv Syst 30(1):47\u201364","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"292_CR100","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","volume":"94","author":"J Bertherat","year":"2009","unstructured":"Bertherat J, Horvath A, Groussin L et al (2009) Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2032-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 94(6):2085\u20132091","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"292_CR101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-011-0935-7","volume":"123","author":"FJ Rodriguez","year":"2012","unstructured":"Rodriguez FJ, Stratakis CA, Evans DG (2012) Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol 123(3):349\u2013367","journal-title":"Acta Neuropathol"},{"key":"292_CR102","doi-asserted-by":"crossref","unstructured":"Pachow D, Wick W, Gutmann DH, Mawrin C (2015) The mTOR signaling pathway as a treatment target for intracranial neoplasms. Neuro-Oncol 17(2):189\u2013199","DOI":"10.1093\/neuonc\/nou164"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-017-0292-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T09:00:03Z","timestamp":1495011603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-017-0292-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1007\/s00292-017-0292-y","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}